“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.”
Chronic pain patients who use herbal cannabis daily for one-year report reduced discomfort and increased quality of life compared to controls, and do not experience an increased risk of serious side effects, according to clinical data published online ahead of print in the Journal of Pain. The study is one of the first ever to assess the long-term safety and efficacy of medicinal cannabis.
Investigators from Leiden University in the Netherlands and the nova-Institut in Germany conducted a systematic review of recent clinical trial data pertaining to the medical use of whole smoked marijuana and cannabinoids.
trials assessing the efficacy of inhaled marijuana consistently show that cannabis holds therapeutic value comparable to conventional medications, according to the findings of a 24-page report issued earlier today to the California state legislature by the California Center for Medicinal Cannabis Research (CMCR).
Today the AMA voted to reverse its longstanding endorsement of cannabis’ Schedule I prohibitive status. The vote took place during the organization’s annual Interim Meeting of the House of Delegates in Houston, Texas, and marks the first time that the AMA has revisited its position on cannabis in eight years.